TEVA

Teva Pharmaceutical Industries
TEVA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$19.49B
EV
$34.74B
Shares Outstanding
1.15B
Beta
0.61

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$23.56
P/E 2025E
6.68x
P/Revenue 2025E
1.15x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Teva Pharmaceutical Industries Limited

gainify
TEVA

Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, s...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Francis, Richard

Employees

37,000

IPO Date

1982-02-16

Headquarters

124 Dvora HaNevi’a Street, Tel Aviv 6944020, Israel

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.